Literature DB >> 7998099

Tolerance induction by soluble CTLA4 in a mouse skin transplant model.

M A Tepper1, P S Linsley, D Tritschler, J M Esselstyn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7998099

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  3 in total

1.  Assessment of dose proportionality, absolute bioavailability, and immunogenicity response of CTLA4Ig (BMS-188667), a novel immunosuppressive agent, following subcutaneous and intravenous administration to rats.

Authors:  N R Srinivas; W C Shyu; R S Weiner; G Warner; C Comereski; L K Tay; D S Greene; R H Barbhaiya
Journal:  Pharm Res       Date:  1997-07       Impact factor: 4.200

2.  Self in vivo production of a synthetic biological drug CTLA4Ig using a minicircle vector.

Authors:  Yeri Alice Rim; Hyoju Yi; Youngkyun Kim; Narae Park; Hyerin Jung; Juryun Kim; Seung Min Jung; Sung-Hwan Park; Ji Hyeon Ju
Journal:  Sci Rep       Date:  2014-11-06       Impact factor: 4.379

3.  In Vivo Imaging of Local Inflammation: Monitoring LPS-Induced CD80/CD86 Upregulation by PET.

Authors:  Marco F Taddio; Claudia A Castro Jaramillo; Peter Runge; Alain Blanc; Claudia Keller; Zeynep Talip; Martin Béhé; Nicholas P van der Meulen; Cornelia Halin; Roger Schibli; Stefanie D Krämer
Journal:  Mol Imaging Biol       Date:  2020-09-28       Impact factor: 3.488
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.